Publications by authors named "Sam Loveless"

Claim this Profile
S
Subcutaneous administration of natalizumab can lead to lower drug concentrations compared to intravenous administration.
Liza M Y Gelissen, Sam Loveless, Alyssa A Toorop, Jayne Howlett, Floris C Loeff

Mult Scler Relat Disord· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relevance of Multiple Sclerosis Severity Genotype in Predicting Disease Course: A Real-World Cohort.
Karim L Kreft, Emeka Uzochukwu, Sam Loveless, Mark Willis, Ray Wynford-Thomas

Ann Neurol· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combination protein biomarkers predict multiple sclerosis diagnosis and outcomes.
Eleftheria Kodosaki, W John Watkins, Sam Loveless, Karim L Kreft, Aidan Richards

J Neuroinflammation· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CCN3 is dynamically regulated by treatment and disease state in multiple sclerosis.
Michelle Naughton, Jill Moffat, George Eleftheriadis, Nira de la Vega Gallardo, Andrew Young, Sam Loveless

J Neuroinflammation· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serum neurofilament-light concentration and real-world outcome in MS.
Valerie Anderson, Emily Bentley, Sam Loveless, Lucia Bianchi, Katharine E Harding

J Neurol Sci· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Using biomarkers to predict clinical outcomes in multiple sclerosis.
Daniel Castle, Ray Wynford-Thomas, Sam Loveless, Emily Bentley, Owain W Howell

Pract Neurol· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Measurement of soluble CD59 in CSF in demyelinating disease: Evidence for an intrathecal source of soluble CD59.
Wioleta M Zelek, Lewis M Watkins, Owain W Howell, Rhian Evans, Sam Loveless

Mult Scler· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tissue microarray methodology identifies complement pathway activation and dysregulation in progressive multiple sclerosis.
Sam Loveless, James W Neal, Owain W Howell, Katharine E Harding, Patrick Sarkies

Brain Pathol· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Complement is activated in progressive multiple sclerosis cortical grey matter lesions.
Lewis M Watkins, James W Neal, Sam Loveless, Iliana Michailidou, Valeria Ramaglia

J Neuroinflammation· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Complement activation in multiple sclerosis plaques: an immunohistochemical analysis.
Gillian Ingram, Sam Loveless, Owain W Howell, Svetlana Hakobyan, Bethan Dancey

Acta Neuropathol Commun· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Complement regulator factor H as a serum biomarker of multiple sclerosis disease state.
Gillian Ingram, Svetlana Hakobyan, Claire L Hirst, Claire L Harris, Trevor P Pickersgill, Sam Loveless

Brain· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis